Muscular involvement is linked with more severe symptoms in people with scleroderma, affecting heart, lungs and the digestive…
Articles by Patricia Inácio, PhD
Treatment with lenabasum failed to outperform a placebo when given as an add-on to standard immunosuppressants in adults…
The Scleroderma Lung Study III (SLSIII), a Phase 2 clinical trial of oral CellCept (mycophenolate mofetil) alone or in combination…
Long stretches of DNA repeats in the FLI1 gene — which gives instructions for a protein that controls the…
Talaris Therapeutics plans to initiate a Phase 1/2a trial to test its investigational cell therapy, FCR001, in people…
The active ingredient in EHP-101 — known as VCE-004.8, derived from synthetic cannabidiol — is not classified as a controlled substance…
The number of treatments for children with rare diseases has grown over the past decade, according to a new study. However,…
The Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Ofev (nintedanib) to preserve…
Inhibiting a protein known as KLHL42 may ease lung fibrosis (scarring) associated with systemic scleroderma (SSc), according to a…
Women with scleroderma take longer to perform daily living tasks, especially those that require hand strength and gripping objects,…